Showing 2,375 news articles about HIV treatment

Filters Content type: Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment guidelines

WHO publishes new clinical recommendations on HIV prevention, infant diagnosis, antiretroviral therapy initiation and monitoring

Editor's pick
World Health Organization
18 March 2021
Adherence

FTC-TP in Dried Blood Spots Predicts Future Detectable Viral Load in US Study

Editor's pick
NATAP
17 March 2021
Cancer

Delayed Start of HIV Therapy Tied to Small Increase in Risk of AIDS-Related Cancers

Editor's pick
Medscape (requires free registration)
17 March 2021
Weight gain & lipodystrophy

HIV research: Increased weight gain with TAF medication

Editor's pick
EurekAlert
17 March 2021
Pregnancy and vertical transmission

Another HIV Tivicay Birth Outcome: Better Infant Survival

Editor's pick
Medscape (requires free registration)
15 March 2021
Injectable & long-acting HIV treatment

Gilead and Merck Announce Agreement to Jointly Develop and Commercialize Long-Acting, Investigational Treatment Combinations of Lenacapavir and Islatravir in HIV

Editor's pick
Gilead press release
15 March 2021
TB treatment

Should TB Treatment Move into Long-Acting Injectables?

Editor's pick
Contagion Live
11 March 2021
Vaccinations & immunisations

US: Interim Guidance for COVID-19 and Persons with HIV

Editor's pick
HIV.gov
1 March 2021
Injectable & long-acting HIV treatment

ViiV Seeks FDA Approval for Cabenuva Dosed Every 2 Months for HIV

Editor's pick
Monthly Prescribing Reference
26 February 2021
HIV treatment

Modern ART paints Soweto bright pink to advertise the latest HIV drug

Editor's pick
Daily Maverick
19 February 2021
New & experimental HIV treatments

ViiV Healthcare receives Marketing Authorisation for Rukobia (fostemsavir), a first-in-class attachment inhibitor in combination with other antiretrovirals for the treatment of adults with multidrug-resistant HIV

Editor's pick
ViiV Healthcare press release
8 February 2021
Antibody-based prevention

Why broadly neutralising antibodies might be the next big thing in HIV

Editor's pick
Spotlight
8 February 2021
Injectable & long-acting HIV treatment

Cabenuva, the First Long-Acting Injectable HIV Regimen, Is Here; Now, Who Will Take It?

Editor's pick
TheBody
29 January 2021
Injectable & long-acting HIV treatment

Previous Intravenous Drug Use May Impact Women's Comfort With Injectable HIV Medications

Editor's pick
American Journal of Managed Care
25 January 2021
Starting treatment

US: Time from entering HIV care to ART prescription has decreased by more than 90%

Editor's pick
Healio
25 January 2021
Injectable & long-acting HIV treatment

FDA approves first long-acting injectable to treat HIV infection

Editor's pick
STAT
22 January 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

Editor's pick
ViiV Healthcare press release
22 January 2021
The search for an HIV prevention vaccine

We Found A COVID-19 Vaccine In Months. What About One For HIV?

Editor's pick
HuffPost
21 January 2021
Bad science & bogus treatments

Fact check: SARS-CoV-2 was not created using genes from HIV, Fauci does not hold patents for an 'HIV component' to SARS-CoV-2

Editor's pick
Reuters
8 January 2021
Bad science & bogus treatments

Fact check: No evidence SARS-CoV-2 is a HIV-based bioweapon; trials show vaccines against the virus are effective

Editor's pick
Reuters
3 January 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

Editor's pick
ViiV Healthcare press release
21 December 2020
Access to healthcare

Malta HIV patients forced to crowdsource medicine

Editor's pick
Deutsche Welle
17 December 2020
The search for an HIV prevention vaccine

Facebook posts make misleading comparison about research into Covid-19, HIV, cancer and common cold

Editor's pick
AFP Factcheck
16 December 2020
New & experimental HIV treatments

ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available

Editor's pick
ViiV Healthcare press release
11 December 2020